BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 27561970)

  • 1. Targeting blood-brain-barrier transcytosis - perspectives for drug delivery.
    Mäger I; Meyer AH; Li J; Lenter M; Hildebrandt T; Leparc G; Wood MJA
    Neuropharmacology; 2017 Jul; 120():4-7. PubMed ID: 27561970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From the Blood to the Central Nervous System: A Nanoparticle's Journey Through the Blood-Brain Barrier by Transcytosis.
    Fullstone G; Nyberg S; Tian X; Battaglia G
    Int Rev Neurobiol; 2016; 130():41-72. PubMed ID: 27678174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.
    Tashima T
    Chem Pharm Bull (Tokyo); 2020; 68(4):316-325. PubMed ID: 32238649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mfsd2a is critical for the formation and function of the blood-brain barrier.
    Ben-Zvi A; Lacoste B; Kur E; Andreone BJ; Mayshar Y; Yan H; Gu C
    Nature; 2014 May; 509(7501):507-11. PubMed ID: 24828040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain delivery research in public-private partnerships: The IMI-JU COMPACT consortium as an example.
    Meyer AH; Untucht C; Terstappen GC
    Neuropharmacology; 2017 Jul; 120():8-10. PubMed ID: 27318272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.
    Stanimirovic DB; Sandhu JK; Costain WJ
    BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
    Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
    Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to identify, engineer, and validate antibodies targeting blood-brain barrier receptor-mediated transcytosis systems for CNS drug delivery.
    Choi ES; Shusta EV
    Expert Opin Drug Deliv; 2023; 20(12):1789-1800. PubMed ID: 38007619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating receptor-mediated antibody transcytosis using blood-brain barrier organoid arrays.
    Simonneau C; Duschmalé M; Gavrilov A; Brandenberg N; Hoehnel S; Ceroni C; Lassalle E; Kassianidou E; Knoetgen H; Niewoehner J; Villaseñor R
    Fluids Barriers CNS; 2021 Sep; 18(1):43. PubMed ID: 34544422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of LDL receptor-targeting peptide vectors for
    Molino Y; David M; Varini K; Jabès F; Gaudin N; Fortoul A; Bakloul K; Masse M; Bernard A; Drobecq L; Lécorché P; Temsamani J; Jacquot G; Khrestchatisky M
    FASEB J; 2017 May; 31(5):1807-1827. PubMed ID: 28108572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies.
    Zuchero YJ; Chen X; Bien-Ly N; Bumbaca D; Tong RK; Gao X; Zhang S; Hoyte K; Luk W; Huntley MA; Phu L; Tan C; Kallop D; Weimer RM; Lu Y; Kirkpatrick DS; Ernst JA; Chih B; Dennis MS; Watts RJ
    Neuron; 2016 Jan; 89(1):70-82. PubMed ID: 26687840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology.
    Moura RP; Martins C; Pinto S; Sousa F; Sarmento B
    Expert Opin Drug Deliv; 2019 Mar; 16(3):271-285. PubMed ID: 30767695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?
    Kreuter J
    Adv Drug Deliv Rev; 2014 May; 71():2-14. PubMed ID: 23981489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcellular brain drug delivery: A review on recent advancements.
    Azarmi M; Maleki H; Nikkam N; Malekinejad H
    Int J Pharm; 2020 Aug; 586():119582. PubMed ID: 32599130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macromolecular drug transport into the brain using targeted therapy.
    Lichota J; Skjørringe T; Thomsen LB; Moos T
    J Neurochem; 2010 Apr; 113(1):1-13. PubMed ID: 20015155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors.
    Kristensen M; Brodin B
    J Pharm Sci; 2017 Sep; 106(9):2326-2334. PubMed ID: 28501469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug targeting to the brain.
    de Boer AG; Gaillard PJ
    Annu Rev Pharmacol Toxicol; 2007; 47():323-55. PubMed ID: 16961459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to CNS Drug Delivery with a Focus on Transporter-Mediated Transcytosis.
    Abdul Razzak R; Florence GJ; Gunn-Moore FJ
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel human induced pluripotent stem cell blood-brain barrier model: Applicability to study antibody-triggered receptor-mediated transcytosis.
    Ribecco-Lutkiewicz M; Sodja C; Haukenfrers J; Haqqani AS; Ly D; Zachar P; Baumann E; Ball M; Huang J; Rukhlova M; Martina M; Liu Q; Stanimirovic D; Jezierski A; Bani-Yaghoub M
    Sci Rep; 2018 Jan; 8(1):1873. PubMed ID: 29382846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.